Multidrug resistance to anti-cancer drugs is a major medical problem.
Resistance is manifested largely by the product of the human MDR1 gene
, P-glycoprotein, an ABC transporter that is an integral membrane prot
ein of 1280 amino acids arranged into two homologous halves, each comp
rising 6 putative transmembrane alpha-helices and an ATP binding domai
n. Despite the plethora of data from site-directed, scanning and domai
n replacement mutagenesis, epitope mapping and photoaffinity labeling,
a clear structural model for P-glycoprotein remains largely elusive.
In this report, we propose a new model for P-glycoprotein that is supp
orted by the vast body of previous data. The model comprises 2 membran
e-embedded 16-strand beta-barrels, attached by short loops to two 6-he
lix bundles beneath each barrel. Each ATP binding domain contributes 2
beta-strands and 1 alpha-helix to the structure. This model, together
with an analysis of the amino acid sequence alignment of P-glycoprote
in isoforms, is used to delineate drug binding and translocation sites
. We show that the locations of these sites are consistent with mutati
onal, kinetic and labeling data.